N	Concordance
1	vival of patients with recurrent and/or metastatic cancer of the cervix treated
2	aware of  the possibility of developing metastatic cancer before a clinical diag
3	o examine consolidation chemotherapy in metastatic cancer patients responding to
4	een few reported visual observations of metastatic cancer cell arrest in vivo. T
5	 accepted definition of the syndrome of metastatic cancer of unknown primary sit
6	  perfusion in patients with primary or metastatic cancer limited to the parench
7	er areas of the body. The risk of these metastatic cancer cells roughly increase
8	bination chemotherapy in a patient with metastatic cancer of unknown primary sit
9	orton has  shown that for patients with metastatic cancer, those receiving the  
10	 survival for patients with advanced or metastatic cancer. Following encouraging
11	r,  and the three most common sites for metastatic cancers are lung, liver,  and
12	er means in patients with localized and metastatic cancers. This assay is highly